ABSTRACT
INTRODUCTION
Primary cilia are dynamic structures, which grow and resorb in response to cues arising from the cell division cycle and the environment (Seeley and Nachury, 2010) . Ciliary dysfunction underlies the pathogenesis of human ciliopathies (Hildebrandt et al., 2011) , a group of inherited developmental disorders that include Joubert Syndrome (JBTS), polycystic kidney disease (PKD), Bardet-Biedel Syndrome, and others. Recent studies have shown that mutations in INPP5E (inositol polyphosphate-5-phosphatase E) cause Joubert Syndrome (Bielas et al., 2009 ) and MORM (mental retardation, truncal obesity, retinal dystrophy and micropenis) (Jacoby et al., 2009 ) thereby linking INPP5E function to primary cilia.
INPP5E is best known for its role in hydrolyzing PtdIns(3,4,5)P 3 and PtdIns(4,5)P 2 , to form PtdIns(3,4)P2 and PtdIns(4)P respectively, creating second messengers that mediate cell responses to various stimuli (Conduit et al., 2012) . INPP5E localizes to the primary cilium and Inpp5e -/-mice develop ciliopathic phenotypes including polycystic kidneys, polydactyly and neural tube closure defects (Jacoby et al., 2009) . They also have abnormally shortened cilia and exhibit decreased stability of pre-established cilia after induction of ciliary disassembly (Jacoby et al., 2009 ). These observations suggested that INPP5E also stabilizes cilia structure and length in growth factor stimulated quiescent cells. INPP5E interacts with several ciliary and centrosomal proteins (ARL13B, PDE6D, and CEP164) that mediate INPP5E targeting to cilium (Humbert et al., 2012) .
However, none of these proteins have been linked to regulation of the stability of primary cilia.
Indeed the mechanism by which loss of INPP5E leads to decreased cilia stability is very poorly understood.
Aurora kinase A is an important regulator of mitosis where it is associated with centrosome maturation and assembly and stability of the spindle body. However a distantly related Chlamydomonas orthologue, CALK, regulates the resorption of the flagella (a structure in some respects analogous to the mammalian cilium) in response to altered ionic conditions or cues for mating (Pan et al., 2004) . Chlamydomonas has proven invaluable in predicting the function of cilia associated genes and these observations suggest an important role for AURKA in the regulation of cilia disassembly. Indeed in mammalian cells AURKA localizes to the basal body of cilia and induces ciliary resorption in response to growth factor stimulation (Pugacheva et al., 2007) . As such it plays a central role as a regulator of cilia stability. Furthermore, AURKA phosphorylation of the polycystic kidney disease protein, PKD2, also influences intracellular calcium levels through a cilia based mechanism (Plotnikova et al., 2011) . Aside from AURKA there are a number of other molecules thought to regulate ciliary resorption including the NIMA-related kinase (NRK) family of proteins found in the highly ciliated organism Tetrahymena (Wloga et al., 2008) . NRKs induce the resorption of specific sets of cilia on the organisms surface. Cilia resorption and accelerated G1-S progression has also been shown to be regulated in mammalian cells as a result of insulin-like growth-1 (IGF-1) activation of its receptor, by way of non-canonical Gβγ signaling and phospho(T94)Tctex-1 present at the base of the cilium (Yeh et al., 2013) . Despite these findings the mechanistic basis for cilia disassembly and importantly, the inter-relationships between the cell signalling pathways involved, remain to be characterised.
In this paper we report a direct functional interaction between INPP5E and AURKA and we demonstrate that this interaction is important for regulating ciliary stability in normal and pathological conditions. These studies establish the first direct link between AURKA and phosphoinositide signalling; observations which will be critical to better understanding the diseases associated with dysregulation of both proteins and the cell signalling pathways they control.
RESULTS

AURKA directly interacts with INPP5E
Given their apparent functional overlap in regulating cilia stability, we first asked whether INPP5E and AURKA themselves interact. Co-immunoprecipitation experiments in transfected kidney cells showed that over-expressed HA-tagged INPP5E bound to both full length RFP-tagged AURKA and its non-catalytic N-terminal regulatory domain, but not to the AURKA catalytic domain alone (Fig. 1A) . Reciprocal interactions were also confirmed between co-overexpressed AURKA and HA-tagged INPP5E (supplementary material Fig. S1A ). We also established that endogenous AURKA and overexpressed INPP5E co-immunoprecipitated from murine inner medullary collecting duct (IMCD3) cells (Fig. 1B) . We then demonstrated that the interaction between these proteins was direct, as purified recombinant AURKA robustly coimmunoprecipitated with purified recombinant GST-INPP5E (Fig. 1C) . These preliminary studies established that INPP5E interacts with AURKA, most likely via direct binding with the AURKA regulatory domain.
INPP5E consists of proline-rich domain that encompasses two SH3 binding sites, the inositol polyphosphate phosphatase catalytic domain (IPPc) and a CaaX motif with an adjacent ciliary targeting sequence (Humbert et al., 2012) . We mapped the minimal domain required for interaction with AURKA to the IPPc region, although the presence of the SH3 binding sites and CaaX domain were able to enhance binding ( Fig. 1D,E) . This is consistent with previous studies
showing that the presence of SH3 domain in NEDD9 is able to mediate its binding with AURKA (Pugacheva and Golemis, 2005) . Whether the SH3 and CaaX sites enhance binding by creating additional contact points between the proteins, by enhancing co-localisation or by contributing to proper protein conformation remains to be determined.
INPP5E localised principally to the ciliary axoneme and to a lesser extent to the basal end of cilia, consistently showing spatial overlap with AURKA ( Fig. 1F , supplementary material S1B).
Importantly, we observed negligible co-localisation of the proteins in any other subcellular compartment. To examine if the ciliary localisation of INPP5E was dependent on AURKA activity, we employed a specific AURKA inhibitor C1368 (Zhang et al., 2006; Plotnikova et al., 2011 ) but this did not alter INPP5E localisation (supplementary material Fig. S1C,D) . Basal body localization of AURKA also was unchanged in the absence of INPP5E (Fig. 3A) .
Interactions between AURKA and INPP5E affect the activity of both proteins AURKA phosphorylates a wide range of protein substrates relevant to the regulation of ciliary disassembly and to other canonical AURKA functions, such as mitotic regulation (Nikonova et al., 2013) . To examine whether INPP5E is a substrate for AURKA, we performed an in vitro kinase assay using recombinant proteins. Recombinant activated AURKA was able to phosphorylate INPP5E ( Fig. 2A ) and the presence of INPP5E in the reaction did not affect AURKA activity on a control substrate, recombinant histone H3 (HH3) ( Fig. 2A ). However the reverse was not the case, as incubation with recombinant AURKA enhanced INPP5E phosphatase activity toward PtdIns(3,4,5)P3 in vitro (Fig. 2B, supplementary material Fig. S2A ). This enhancement required AURKA catalytic activity, as inhibition of AURKA with its inhibitor C1368 in INPP5E
transfected HEK293 cells caused a dose-dependent decrease in 5-phosphatase activity (Fig. 2C, supplementary material Fig. S2B-D ).
These observations indicate that, in isolation, direct interaction with INPP5E does not affect the activation of AURKA. We next wished to determine whether this was the case in cells. A common mechanism for AURKA activation is via auto-phosphorylation of threonine 288 (Walter et al., 2000) . Although T288 AURKA phosphorylation was not demonstrably altered by interactions between recombinant proteins in vitro ( Fig. 2A) we did observe marked increases in AURKA autophosphorylation upon co-expression of INPP5E and AURKA in cells (Fig. 2D ), as well as concomitant increases in phosphorylation of the AURKA substrate HH3 (Fig. 2E,F (Horan et al., 2007) , did not increase AURKA T288 phosphorylation ( Fig. 2D-F ). For both AURKA and INPP5E, protein-protein interaction appeared to be dependent on catalytic function, as the capacity of D480N-INPP5E to bind AURKA was also abrogated, while a kinase dead version of AURKA (K162D) (Cheetham et al., 2002) was less able to bind INPP5E (Fig. 2E,F) . To confirm that this change in binding was derived from altered activity and not from a specific conformational change associated with the D480N mutation, we tested whether a range of Joubert Syndrome (JBTS) missense mutations in INPP5E could influence AURKA binding and activity. Importantly, these changes are in different parts of the 5-phosphatase domain of the protein but all are thought to disrupt the phosphatase activity of INPP5E toward PtdIns(3,4,5)P 3 (Bielas et al., 2009 ). Overexpression of V5-tagged wild type and INPP5E variants demonstrated that JBTS missense mutants were unable to induce AURKA phosphorylation (Fig. 2G) or to interact with AURKA ( Fig. 2H ). Given the disparate nature of these changes, our findings suggested that both the activation of AURKA by INPP5E and the physical interaction of the proteins relied upon the capacity of INPP5E to dephosphorylate or bind PtdIns(3,4,5)P 3 .
Given these observations we hypothesized that the changes in activity and interaction might be mediated in some way by the relative levels of INPP5E metabolites. To investigate this possibility, we co-expressed AURKA with the 4-phosphatase INPP4B, which reduces levels of PtdIns(3,4)P 2 , the product of PI(3,4,5)P 3 hydrolysis mediated by INPP5E (Kisseleva et al., 2002) . In doing so we blocked the activation of AURKA but did not change the interaction between AURKA and INPP5E ( Fig. 2I ), indicating that only activation required the presence of PtdIns(3,4)P2.
AURKA levels are regulated by INPP5E
To establish the relevance of INPP5E-AURKA interactions in a physiological setting, we obtained embryonic fibroblasts (MEFs) from Inpp5e -/-embryos, which phenocopy those mouse models described previously (Jacoby et al., 2009) . AURKA localises to the ciliary basal body in mammalian cells, where it regulates ciliary disassembly through interactions with NEDD9 and other proteins (Pugacheva et al., 2007) . Increases in phosphorylation of AURKA are linked to increased cilia disassembly (Pugacheva et al., 2007; Plotnikova et al., 2012) , while Inpp5e -/-MEFs have ciliary disassembly defects (Jacoby et al., 2009) . In serum starved primary fibroblasts from
Inpp5e
-/-mice, we observed an increase in levels of phosphorylated AURKA compared to wild type cells. This differential was exacerbated upon treatment with serum to induce ciliary disassembly (Fig. 3A) . Unexpectedly, analysis of total AURKA levels in Inpp5e -/-MEFs ( One mechanism by which AURKA protein levels are regulated is through proteasome mediated degradation of AURKA (Walter et al., 2000) , but cycloheximide block-chase experiments indicated that this was not affected by INPP5E (supplementary material Fig. S3B ). Instead, we found that Aurka mRNA expression in Inpp5e -/-fibroblasts was significantly increased compared to wild type cells (Fig. 3E) . Previous studies have shown that Aurka expression is regulated by AKT, a downstream mediator of phosphoinositide signalling (Liu et al., 2008) . Decreased AKT phosphorylation has been reported in cell lines over-expressing Inpp5e (Kisseleva et al., 2002 ) and depletion of INPP5E or expression of JBTS mutants lacking 5-phosphatase activity in HEK293 cells, results in elevated phospho-AKT (Bielas et al., 2009) . INPP5E primarily regulates AKT activity through hydrolysis of PtdIns(3,4,5)P 3 , which is essential for its effective activation (Kisseleva et al., 2002) . Consistent with these previous findings we found that Inpp5e -/-MEFs had increased levels of steady state AKT and phospho-AKT (Fig. 3B) , suggesting that increases in AURKA were mediated by AKT signalling. To test this hypothesis, we examined the dynamic changes in AURKA levels at different time points following INPP5E overexpression.
Overexpression of INPP5E decreased the amount of AURKA in a time-dependent manner, and was accompanied by decreased AKT phosphorylation (Fig. 3F,G) . To further evaluate how INPP5E
governs Aurka expression through a phospho-AKT-dependent mechanism, we examined AURKA levels in IMCD3 cells treated with siINPP5E or scrambled control siRNA with or without the wellvalidated AKT inhibitor, MK2206 (Pal et al., 2010) . Inhibition of AKT phosphorylation with MK2206 abolished the increase in AURKA levels upon INPP5E siRNA transfection, in a time dependent manner ( Fig. 3H,I ; supplementary material Fig. S3C,D) . We obtained simular results using another AKT inhibitor AKTiX (Bertotti et al., 2009 ) (Supplementary material Fig. S3E-I ).
These results confirmed that INPP5E regulates AURKA protein levels by transcriptional mechanisms that are mediated at least in part by AKT activity.
Functional dissection of the role of the AURKA/INPP5E interaction in primary cilia
Increases in cellular levels of phospho-AURKA are associated with an increase in cilia disassembly (Pugacheva et al., 2007; Plotnikova et al., 2012) and similar defects are observed in
Inpp5e
-/-cells (Bielas et al., 2009 ). To determine whether there was a shared functional basis to these phenotypes, we serum starved fibroblasts from wild type and Inpp5e -/-mice and profiled cilia disassembly upon addition of serum in the presence or absence of an AURKA inhibitor (C1368) or vehicle control (DMSO). This experiment confirmed the reduced number of ciliated Inpp5e -/-MEFs at 2-4 h after serum application compared with wild type controls (Bielas et al., 2009 ) and showed that AURKA inhibition rescued the ciliary disassembly defects associated with loss of INPP5E (Fig. 4A) . We obtained similar results using another AURKA inhibitor, MLN8237 (supplementary material Fig. S4A ) and also in experiments depleting INPP5E in the IMCD3 cell line (supplementary material Fig S4B) . Thus, inhibition of AURKA is able to restore normal cilia stability in cells lacking INPP5E, demonstrating an opposing role for the two proteins in controlling cilia stability.
Primary cilia are also known to play a central role in mediating cell polarity and lumen formation in cultured kidney cells (and in renal cysts). In addition to other ciliopathy features,
-/-mice also develop renal cysts, a phenotype which is frequently associated with primary cilium defects (Jacoby et al., 2009) . Taking into account the previously described role for AURKA in PKD (Plotnikova et al., 2011) and in the regulation of primary cilia stability (Pugacheva et al., 2007; Plotnikova et al., 2012) , we evaluated the impact of altered AURKA function in a cellular model of INPP5E-dependent cyst formation. To examine whether the AURKA/INPP5E complex impacted these features, we depleted INPP5E in IMCD3 cells and grew them in 3D matrigel matrix.
The resulting cell colonies failed to form spheroids and instead developed as clusters of cells with 9 irregular or non-existent lumens, randomly oriented shortened cilia and a lack of polarized expression of E-cadherin (Fig. 4B) . These features are a common characteristic of cyst-lining cells (Wilson, 2004) . To examine whether these phenotypes were a consequence of INPP5E mediated dysregulation of AURKA, we treated the cultures with the AURKA inhibitor C1368. Doing so resulted in a striking rescue of spheroid formation and an increase in the length of luminal cilia (Fig.   4B, C) . Taken together, these findings indicate that AURKA plays a critical part in mediating the ciliary defects observed in Inpp5e -/-mice and suggest that manipulation of AURKA activity might influence cyst formation.
DISCUSSION
We have described a complex inter-relationship between the 5-phosphatase INPP5E and the AURKA kinase which regulates the activity of both proteins at the primary cilium. We propose that hydrolysis of PtdIns(3,4,5)P 3 by INPP5E alters the levels of different phosphoinositide species and in so doing mediates the functional interaction between INPP5E and AURKA, resulting in the activation of the latter protein through auto-phosphorylation (Fig. 5A) . The mechanism by which this occurs remains to be determined. Activated AURKA binds and phosphorylates INPP5E, thereby increasing its phosphatase activity and hydrolysis of PtdIns(3,4,5)P 3 , establishing a feedforward loop which down regulates AKT activity and a feed-back loop which reduces Aurka transcription (Fig. 5B ). Both AURKA ( Fig. 1F and (Pugacheva et al., 2007) and AKT (Schneider et al., 2010) are detected at the base of primary cilia and INPP5E is detected along the ciliary axoneme, extending to the base ( Fig.1F and (Bielas et al., 2009)) suggesting that the crosstalk between these proteins might occur within primary cilia. Importantly, the only significant colocalization between the two proteins was detected at the ciliary basal body. However, further studies are required to precisely define the location and dynamics of this interaction.
We show that when INPP5E is deleted or mutated (as in Joubert Syndrome), changes in the total level of AKT elevate AURKA gene transcription, resulting in a generalized accumulation of AURKA protein at the cilia. In response to physiological stimuli (e.g. growth factors) we propose that the increased pool of AURKA at this site drives the abnormal cilia disassembly phenotype observed in Inpp5e -/-MEFs (Fig.5C ). One prediction of this model is that inhibiting AURKA should be able to rescue defects caused by loss of INPP5E. We have observed exactly this effect in the context of cilia stability defects in response to growth factor signaling and in rescuing the defective cystogenesis apparent upon INPP5E deletion/knockdown. Given the complex nature of this interaction, understanding the consequences of perturbation in vivo will require further investigation.
The work presented here reveals a novel function of AURKA, suggesting that it acts as both a target and a regulator of phosphoinositide signalling. These findings have considerable implications for our understanding of the mechanisms which drive the development of disease phenotypes in the ciliopathies and in particular it provides a link between phosphoinositide signaling and the development of renal cysts. Mutations in INPP5E give rise to two clinically distinct diseases; Joubert Syndrome and MORM. The former condition is caused principally by point mutations in the catalytic domain of the protein which alter the phosphatase activity of the enzyme (Bielas et al., 2009) . The latter disease is instead caused by C-terminal truncating mutations which affect ciliary localization, but which do not appear to alter the enzymes phosphatase activity (Jacoby et al., 2009) . Given that the interactions between AURKA and INPP5E are significantly regulated by catalytic activity it is possible that the clinical differential between these diseases may in some manner be shaped by INPP5E's interactions with AURKA.
More broadly, a number of cancers are characterized by hyper-activation of phosphoinositide signaling (Jaiswal et al., 2009 ) and increases in AURKA protein levels and activity (Gautschi et al., 2008) . The complex functional interaction between INPP5E and AURKA described in this report will therefore be important to investigate in this context. (Humbert et al., 2012) . Mouse primary fibroblasts (MEFs) were harvested from the E12.5 embryos. The embryos were harvested, heart and digestive system were discarded and the rest was minced, washed and placed in a 10 mL conical tube to incubate in TrypLE trypsin (Gibco Life Technologies) for 15 min at 37°C with constant shaking at 150 rpm, then centrifuged to spin down and washed in PBS buffer (Gibco Life Technologies) (Xu, 2005) . MEFs and HEK293 cells were maintained in DMEM with 10% fetal bovine serum. IMCD3 cells were grown in DMEM/F-12 supplemented with 10% fetal bovine serum (Gibco Life Technologies). All media were supplemented with 100 U/ml penicillin, and 100 μg/ml streptomycin (Life Technologies). Immunofluorescence. Cells growing on coverslips or in chamber slides were fixed with 4% paraformaldehyde (10 min), permeabilized with 1% Triton X-100 in phosphate-buffered saline (PBS), blocked in 1×PBS with 3-5% BSA, and incubated with antibodies using standard protocols. (1:200) and rabbit anti-E-cadherin antibody (Life Technologies) (1:400). Secondary antibodies labelled with Alexa 488, Alexa 568, and 4′,6-diamidino-2-phenylindole (DAPI) to stain DNA were from Life Technologies. Confocal microscopy was performed using a Nikon C1 Spectral confocal microscope (Nikon) equipped with a numerical aperture (NA) 1.40, oil immersion, 60× Plan Apo objective (Nikon). Images were acquired at room temperature using EZ-C1 3.8 software (Nikon) and analyzed using MetaMorph (Molecular Devices) and Photoshop, version CS2 (Adobe)
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software. Adjustments to brightness and contrast were minimal and were applied to the whole image.
Fluorescence intensity measurements
Relative intensity was measured as the fluorescence intensity normalised to the WT under no serum NaCl, 10mM EDTA) to the kinase reaction mix at 37 C for 10 min, followed by malachite green incubation (Echelon Inc) for an additional 10-20 min (Vandeput et al., 2006) . 
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